Skip to main content
. 2008 Nov 1;43(4):372–375. doi: 10.1016/j.jcv.2008.08.020

Table 4.

Expected test savings (in terms of mastermix) for each disease syndrome/sample type.

Sample Annual total Number of tests carried out (pre-multiplex) Number of test carried out (post-multiplex) Total difference (%)
Eye ∼2,000 8,000 2,000 75
Stool (non-outbreak) ∼1,600 6,400 1,600 75
CSF ∼1,600 11,200 6,400 43
Vesicle fluid ∼2,000 4,000 2,000 50
Genital ∼2,000 2,000 2,000 0
Blood (TX) ∼3,000 9,000 3,000 66



Total ∼12,200 40,600 17,000 58.2